Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedEval Clinic was a private U.S. medical cannabis evaluation and education center group founded in 2014. The company operated clinics in Colorado and Arizona, helping patients obtain medical cannabis evaluations, certifications, and related education rather than developing proprietary therapeutics. In March 2019, CB2 Insights agreed to acquire MedEval Clinic, and the transaction closed in April 2019 as part of CB2's strategy to build a multi-state network of cannabis evaluation clinics and real-world evidence assets. MedEval therefore appears best characterized as a healthcare service provider in the medical cannabis ecosystem, not a biotech or drug-development company. The original standalone business and brand appear inactive following the acquisition, and its former domain is no longer operating as an official company website.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedEval Clinic.